Why is there some Mounjaro left in the pen after your injection?

What the Mounjaro SmPC says about residual liquid in the cartridge

The Mounjaro patient information leaflet and SmPC (the definitive reference documents reviewed and authorised by the MHRA) explain that KwikPens are manufactured with a deliberate overfill. This is standard practice across injectable medicines: because surface tension, dead space in the needle hub, and the mechanics of the plunger mean a small volume never exits the cartridge, manufacturers add a buffer at production so the patient always receives the correct therapeutic amount. The result is that a pen delivering, say, 5 mg of tirzepatide will contain visibly more than 5 mg worth of liquid when new. After injection, some of that buffer stays behind.

This is not a manufacturing fault. The NHS medicines page for tirzepatide reinforces this point: patients are advised to use each pen once, then dispose of it, without trying to extract the remaining fluid. If you are ever uncertain whether your pen functioned correctly, the instruction is to check the dose indicator rather than the volume of liquid left.

You can read further detail about how the KwikPen is designed in the guide to Mounjaro injections on this site.

How to tell whether your dose was actually delivered

The KwikPen has a dose indicator window that moves as the plunger travels. Once the indicator reaches zero and the plunger button cannot be pressed further, the dose is complete, full stop. Liquid remaining in the cartridge at that point is the overfill doing its job. The NHS guidance on tirzepatide also notes that if the indicator does not reach zero, or the button felt unusually easy to press throughout, you should contact your prescriber or the pharmacy before attempting another injection.

A question our prescribers hear fairly often is whether the small bubble visible in the pen alongside the remaining liquid is also a problem. Short air bubbles in a subcutaneous injection pen are generally not clinically significant in the way they would be for an intravenous medicine, but the SmPC's instruction is clear: inject as directed, then stop. If there is visible liquid before you inject rather than after (meaning the pen looks underfilled compared with a previous pen at the same dose) that is worth noting. Our page on why there is liquid left in your Mounjaro pen explains the mechanics behind this in more detail, and if you are specifically wondering why there is Mounjaro left in the pen after a completed injection, that guide walks through the manufacturing reasons in plain terms.

For anything that feels like a device malfunction, Eli Lilly's UK medical information team can be contacted directly, and your prescriber should always be the first call if you are unsure whether your dose went in correctly.

Why you should not inject the residual liquid

It can feel counterintuitive to leave liquid in a pen, particularly given what tirzepatide costs privately. The residual volume is real, but it exists to serve the delivered dose, it is not a bonus. Attempting to inject it by pressing the button harder, tilting the pen, or removing the cartridge would mean administering an unknown and unlabelled quantity of tirzepatide on top of the dose you have already received.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, and its gastrointestinal side effects (nausea, vomiting, diarrhoea) are dose-related. An unintended extra fraction of the medicine, particularly at higher doses, could intensify those effects unnecessarily. The MHRA, which regulates Mounjaro in the UK, is clear that patients should follow the instructions in the PIL precisely. If you want to understand more about what it means when there is some Mounjaro left in the pen and whether that amount is normal, that page sets out what to expect at each dose strength. If you are new to tirzepatide or want a broader overview of the medicine, the Mounjaro information page covers how it works, the titration schedule, and what to expect.

Dispose of used pens promptly in a sharps container, a 1-litre sharps bin is the recommended household option and can be collected by your local council once full. Never put a used pen in your household bin or recycling.

When residual liquid might point to a genuine injection problem

Most of the time, some liquid left in a Mounjaro pen is simply the system working as intended. There are a handful of situations, though, where it is worth pausing. If the dose indicator has not reached zero, the pen was dropped or damaged before use, or the pen was stored at room temperature for longer than the window specified in your patient information leaflet (always check the leaflet for the exact figure, as this varies by storage history), then the integrity of the dose may be in question.

Similarly, if you notice what looks like particles or discolouration in the remaining liquid, do not use that pen again and contact your prescriber. Tirzepatide solution should be clear and colourless to slightly yellow. Anything else is a reason to call, not to inject.

If you have further questions specific to your prescription or want to clarify something about your treatment, our frequently asked questions page covers common injection queries, or you can reach our team directly via the contact page. Every patient at nume has access to priority aftercare seven days a week, so no injection question goes unanswered. If you are not yet on treatment and would like to explore whether tirzepatide is suitable for you, check your eligibility with a free consultation, a GPhC-registered prescriber, not an automated system, reviews every application the same day it arrives.